Adjust assumptions
Adjust the usable peer mix to see how each valuation multiple moves the blended fair value.
Peer-implied fair value
$596.87
Blended value per share under the current mix.
Current price
—
Market price unavailable
Peer gap
N/A
Peer gap unavailable
Weighting mixer
Value contribution
4 peers →Price / Sales
$773.94B
Price / Earnings
$664.45B
Price / Sales
$1.55T
Price / Earnings
$1.33T
Equal-weight baseline
Premium 0.0%The simple average of every usable peer method, before your weighting adjustments.
Baseline equity value
$1.44T
Baseline / share
$596.87
Relative valuation prices this company against what the market already pays for its peers. For a cash-flow view that does not inherit peer sentiment, open the intrinsic model.
Spreadsheet data
Audit the saved peer set and the method inputs behind the blended fair value.
The saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market cap | Enterprise value | Revenue | EBITDA | Net income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
PFE PFIZER INC FY ended Feb 19, 2026 | — |
Which peer averages feed the weighted fair value, and which methods are excluded.
| Method | Type | Avg. multiple | Coverage | Implied equity value | Fair value / share | Status |
|---|---|---|---|---|---|---|
| — |
| — |
| $62.58B |
| $15.48B |
| $7.77B |
| — |
| — |
| — |
LLY ELI LILLY & Co FY ended Feb 09, 2026 | $1,137.82 | $1.07T | — | $65.18B | $28.02B | $20.64B | 49.58x | 16.43x | — |
ABT ABBOTT LABORATORIES FY ended Jan 31, 2026 | — | — | — | $44.33B | $12.22B | $6.52B | — | — | — |
AMGN AMGEN INC FY ended Feb 10, 2026 | — | — | — | $36.75B | $14.04B | $7.71B | — | — | — |
PFE
PFIZER INC
—
—
—
$62.58B
$15.48B
—
—
—
Cap —EV —Rev $62.58BEBITDA $15.48BP/E —P/S —EV/EBITDA —
LLY
ELI LILLY & Co
$1,137.82
$1.07T
—
$65.18B
$28.02B
49.58x
16.43x
—
Cap $1.07TEV —Rev $65.18BEBITDA $28.02BP/E 49.58xP/S 16.43xEV/EBITDA —
ABT
ABBOTT LABORATORIES
—
—
—
$44.33B
$12.22B
—
—
—
Cap —EV —Rev $44.33BEBITDA $12.22BP/E —P/S —EV/EBITDA —
AMGN
AMGEN INC
—
—
—
$36.75B
$14.04B
—
—
—
Cap —EV —Rev $36.75BEBITDA $14.04BP/E —P/S —EV/EBITDA —
| Enterprise Multiple |
| — |
| 0/4 |
| — |
| — |
| No saved peers have usable coverage for this method. |
Price / Sales PSActive | Equity Multiple | 16.43x | 1/4 | $1.55T | $642.30 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 49.58x | 1/4 | $1.33T | $551.43 | Included in the active peer mix. |
EV / EBITDA
EV · Enterprise Multiple
Avg. multiple
—
Coverage
0/4
Implied equity value
—
Fair value / share
—
No saved peers have usable coverage for this method.
Price / Sales
PS · Equity Multiple
Avg. multiple
16.43x
Coverage
1/4
Implied equity value
$1.55T
Fair value / share
$642.30
Included in the active peer mix.
Price / Earnings
PE · Equity Multiple
Avg. multiple
49.58x
Coverage
1/4
Implied equity value
$1.33T
Fair value / share
$551.43
Included in the active peer mix.
